Dr. Cansu Babahan

Ankara University Cancer Research Institute
Antibodies and Peptides Unit

She graduated from Hacettepe University, Department of Biology. She completed her master’s in Tumor Biology at Ankara University Institute of Health Sciences with her thesis titled “The Effect of PD-L1 Expression on Angiogenesis and Invasion in Tumor Cells”. Then, she completed the Tumor Biology Doctorate Program at Ankara University Institute of Health Sciences in 2023 with her thesis titled “Development of Anti-PD-L1-scFv Antibodies for Use in Cancer Diagnosis and Treatment”. 

She has experience in TUBITAK 1001, 1003 and 1004 projects and continues to work on projects titled “Production of Adenoviral-Based Vaccine Against COVID-19” within the scope of TÜBİTAK 1004 Virus-Based Prototype Coronavirus Vaccine Production Project and “Development of Biotechnological Vaccine Formulas for H9N2 Avian Influenza” within the scope of the Prevention and Treatment National Platform project supported by TÜBİTAK 1004 Center of Excellence Support Program.